Cargando…
Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings—a gap that could be addressed us...
Autores principales: | Belcher, Annabelle M., Coble, Kelly, Cole, Thomas O., Welsh, Christopher J., Whitney, Anna, Weintraub, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585441/ https://www.ncbi.nlm.nih.gov/pubmed/34777036 http://dx.doi.org/10.3389/fpsyt.2021.703685 |
Ejemplares similares
-
Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021) -
Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
por: Nguyen, Andrea, et al.
Publicado: (2023) -
HIV and incarceration: prisons and detention
por: Jürgens, Ralf, et al.
Publicado: (2011) -
Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019) -
Pandemic detention: life with COVID-19 behind bars in Maryland
por: Arscott, Joyell, et al.
Publicado: (2023)